January
9
Exagen and Queen Mary University of London Announce Exclusive License and Collaboration Agreement
Collaboration to develop novel patented molecular signatures for rheumatoid arthritis biologic therapeutic selection SAN...
News
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.